Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect.

Levine MS, Cepeda C, Hickey MA, Fleming SM, Chesselet MF.

Trends Neurosci. 2004 Nov;27(11):691-7. Review.

PMID:
15474170
2.

Transgenic mouse models of Parkinson's disease and Huntington's disease.

Skaper SD, Giusti P.

CNS Neurol Disord Drug Targets. 2010 Aug;9(4):455-70. Review.

PMID:
20522011
3.

Normal CAG and CCG repeats in the Huntington's disease genes of Parkinson's disease patients.

Rubinsztein DC, Leggo J, Goodburn S, Barton DE, Ferguson-Smith MA.

Am J Med Genet. 1995 Apr 24;60(2):109-10.

PMID:
7485243
4.

The use of stem cells in regenerative medicine for Parkinson's and Huntington's Diseases.

Lescaudron L, Naveilhan P, Neveu I.

Curr Med Chem. 2012;19(35):6018-35. Review.

PMID:
22963567
5.

Animal models of Alzheimer's Parkinson's and Huntington's disease. A minireview.

Antal A, Bodis-Wollner I.

Neurobiology (Bp). 1993;1(2):101-22. Review.

PMID:
8111350
6.

Inhibitory control during smooth pursuit in Parkinson's disease and Huntington's disease.

Henderson T, Georgiou-Karistianis N, White O, Millist L, Williams DR, Churchyard A, Fielding J.

Mov Disord. 2011 Aug 15;26(10):1893-9. doi: 10.1002/mds.23757. Epub 2011 May 31.

PMID:
21630355
7.

The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.

Huot P, Lévesque M, Parent A.

Brain. 2007 Jan;130(Pt 1):222-32. Epub 2006 Dec 2.

PMID:
17142832
8.

Neurodegenerative disorders: Parkinson's disease and Huntington's disease.

Hague SM, Klaffke S, Bandmann O.

J Neurol Neurosurg Psychiatry. 2005 Aug;76(8):1058-63. Review.

9.

Of molecular interactions, mice and mechanisms: new insights into Huntington's disease.

Wellington CL, Hayden MR.

Curr Opin Neurol. 1997 Aug;10(4):291-8. Review.

PMID:
9266152
10.

Animal models of Huntington's disease.

Gárdián G.

Ideggyogy Sz. 2006 Nov 20;59(11-12):396-9. Review.

PMID:
17203874
11.

Applications of lentiviral vectors for biology and gene therapy of neurological disorders.

Lundberg C, Björklund T, Carlsson T, Jakobsson J, Hantraye P, Déglon N, Kirik D.

Curr Gene Ther. 2008 Dec;8(6):461-73. Review.

PMID:
19075629
12.

Molecular genetics of Huntington's disease.

Gusella JF, MacDonald ME, Ambrose CM, Duyao MP.

Arch Neurol. 1993 Nov;50(11):1157-63. Review.

PMID:
8215974
13.

Histone post-translational modifications in Huntington's and Parkinson's diseases.

Peña-Altamira LE, Polazzi E, Monti B.

Curr Pharm Des. 2013;19(28):5085-92. Review.

PMID:
23448464
14.

Proprioceptive sensory function in Parkinson's disease and Huntington's disease: evidence from proprioception-related EEG potentials.

Seiss E, Praamstra P, Hesse CW, Rickards H.

Exp Brain Res. 2003 Feb;148(3):308-19. Epub 2002 Nov 30.

PMID:
12541142
15.

Genetic neurodegenerative diseases: the human illness and transgenic models.

Price DL, Sisodia SS, Borchelt DR.

Science. 1998 Nov 6;282(5391):1079-83. Review.

PMID:
9804539
17.

Yeast as a drug discovery platform in Huntington's and Parkinson's diseases.

Outeiro TF, Giorgini F.

Biotechnol J. 2006 Mar;1(3):258-69. Review.

PMID:
16897706
18.

Excitotoxicity of L-dopa and 6-OH-dopa: implications for Parkinson's and Huntington's diseases.

Olney JW, Zorumski CF, Stewart GR, Price MT, Wang GJ, Labruyere J.

Exp Neurol. 1990 Jun;108(3):269-72.

PMID:
1972067
19.

Genes and the environment in neurodegeneration.

Coppedè F, Mancuso M, Siciliano G, Migliore L, Murri L.

Biosci Rep. 2006 Oct;26(5):341-67. Review.

PMID:
17029001
20.

Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases.

Alexi T, Borlongan CV, Faull RL, Williams CE, Clark RG, Gluckman PD, Hughes PE.

Prog Neurobiol. 2000 Apr;60(5):409-70. Review.

PMID:
10697073

Supplemental Content

Support Center